High-dose VP-16-213 monotherapy for refractory germinal malignancies: A phase II study

S. N. Wolff, D. H. Johnson, J. D. Hainsworth, F. A. Greco

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Fingerprint

Dive into the research topics of 'High-dose VP-16-213 monotherapy for refractory germinal malignancies: A phase II study'. Together they form a unique fingerprint.